Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3481]
News [8235]
Articles [66]
Editorials [9]
Conferences [224]
elearning [49]
New approach to overcoming TKI resistance
New approach to overcoming TKI resistance
Imatinib-intolerant patients with CML are minimally cross-intolerant to nilotinib
Imatinib-intolerant patients with CML are minimally cross-intolerant to nilotinib
DNA replication emzyme could be anti-cancer drug target
DNA replication emzyme could be anti-cancer drug target
New developments in drug therapy for hepatitis C
New developments in drug therapy for hepatitis C
FDA go ahead for sunitinib for pancreatic tumours
FDA go ahead for sunitinib for pancreatic tumours
Potential anti-cancer compounds target aneuploidy
Potential anti-cancer compounds target aneuploidy
Developments in personalised medicine for cancer
Developments in personalised medicine for cancer
AACR 2011: New drugs on the horizon
AACR 2011: New drugs on the horizon
AACR 2011: Immune system may guide chemotherapy for breast cancer
AACR 2011: Immune system may guide chemotherapy for breast cancer
AACR 2011: Combining MEK and PI3K inhibitors encouraging for early signs of anti-tumour activity
AACR 2011: Combining MEK and PI3K inhibitors encouraging for early signs of anti-tumour activity

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation